Background: Membranous nephropathy(MN)is a leading cause of nephrotic syndrome in adu1ts,and anti-M-type phospholipase A2 receptor(anti-PLA2R)antibodies are found in the majority of patients with idio
Introduction: The purpose of the study is to evaluate the efficiency and safety of tacrolimus(TAC)monotherapy in the treatment of nephrotic idiopathic membranous nephropathy(IMN)compared with the prot